|
Delayed
TEL AVIV STOCK EXCHANGE
02:59:21 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 1,689.00 ILa | 0.00% |
|
+4.97% | +4.39% |
| 09-08 | InterCure Regains Nasdaq Compliance | MT |
| 08-24 | InterCure Ltd. announced that it has received ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors. | CI |
EPS & Dividend: InterCure Ltd.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -7.33 | 0.5 | 4.941 | -6.8 | -7.4 | -3.322 |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 81.76 | 103.60 | 60.40 | 23.16 | 29.69 | 16.18 |
| Nbr of stocks (in thousands) | 5,388 | 8,999 | 9,115 | 9,115 | 9,153 | 10,936 |
| Announcement Date | 3/31/21 | 4/5/22 | 3/31/23 | 5/1/24 | 5/1/25 | 4/30/26 |
1ILS in Million2ILS
Estimates
Past dividends: InterCure Ltd.
| 2026-08-24 | Significant Split/Dividend | 00:00 |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 3.08% | 3.17% | 12.58x | 1.38x | 0.39x | |
| 0.73% | 0.76% | 14.42x | -10.47x | 1.81x | |
| -.--% | -.--% | -290x | 30.48x | 19.96x | |
| 2.68% | 2.88% | 13.32x | 1.24x | 1.47x | |
| 1.42% | 1.41% | 22.96x | 3.2x | 2.57x | |
| 0.94% | 0.95% | 22.14x | 2.79x | 2.05x | |
| 2.27% | 2.72% | 30.79x | 8.83x | 5.56x | |
| -.--% | -.--% | 7.85x | 3.5x | 1.42x | |
| 1.47% | 1.64% | 30.49x | 2.11x | 2.86x | |
| Average | 1.4% | 1.5% | -15.05x | 4.78x | 4.23x | |
| Weighted average by Cap. | 1.54% | 1.62% | -29.06x | 3.68x | 4.37x |
Select your edition
All financial news and data tailored to specific country editions
